Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635 (c) (4) MALVERN, Pa., June 19, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology ...

Neuronetics Inc. stock grades by Barron's. View STIM fundamental and sentiment analysis powered by MarketGrader.

Neuronetics Inc. research and ratings by Barron's. View STIM revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.